UNLABELLED: Myeloid cell leukemia-1 (Mcl-1) is an antiapoptotic member of the Bcl-2 protein family. It interacts with proapoptotic Bcl-2 family members, thereby inhibiting mitochondrial activation and induction of apoptosis. Mcl-1 is essential for embryonal development and the maintenance of B cells, T cells, and hematopoietic stem cells. We have recently shown that induction of Mcl-1 by growth factors rescues primary human hepatocytes from CD95-mediated apoptosis. This prompted us to further analyze the relevance of Mcl-1 for hepatocellular homeostasis. Therefore, we generated a hepatocyte-specific Mcl-1 knockout mouse (Mcl-1(flox/flox)-AlbCre). Deletion of Mcl-1 in hepatocytes results in liver cell damage caused by spontaneous induction of apoptosis. Livers of Mcl-1(flox/flox)-AlbCre mice are smaller compared to control littermates, due to higher apoptosis rates. As a compensatory mechanism, proliferation of hepatocytes is enhanced in the absence of Mcl-1. Importantly, hepatic pericellular fibrosis occurs in Mcl-1 negative livers in response to chronic liver damage. Furthermore, Mcl-1(flox/flox)-AlbCre mice are more susceptible to hepatocellular damage induced by agonistic anti-CD95 antibodies or concanavalin A. CONCLUSION: The present study provides in vivo evidence that Mcl-1 is a crucial antiapoptotic factor for the liver, contributing to hepatocellular homeostasis and protecting hepatocytes from apoptosis induction.
UNLABELLED: Myeloid cell leukemia-1 (Mcl-1) is an antiapoptotic member of the Bcl-2 protein family. It interacts with proapoptotic Bcl-2 family members, thereby inhibiting mitochondrial activation and induction of apoptosis. Mcl-1 is essential for embryonal development and the maintenance of B cells, T cells, and hematopoietic stem cells. We have recently shown that induction of Mcl-1 by growth factors rescues primary human hepatocytes from CD95-mediated apoptosis. This prompted us to further analyze the relevance of Mcl-1 for hepatocellular homeostasis. Therefore, we generated a hepatocyte-specific Mcl-1 knockout mouse (Mcl-1(flox/flox)-AlbCre). Deletion of Mcl-1 in hepatocytes results in liver cell damage caused by spontaneous induction of apoptosis. Livers of Mcl-1(flox/flox)-AlbCre mice are smaller compared to control littermates, due to higher apoptosis rates. As a compensatory mechanism, proliferation of hepatocytes is enhanced in the absence of Mcl-1. Importantly, hepatic pericellular fibrosis occurs in Mcl-1 negative livers in response to chronic liver damage. Furthermore, Mcl-1(flox/flox)-AlbCre mice are more susceptible to hepatocellular damage induced by agonistic anti-CD95 antibodies or concanavalin A. CONCLUSION: The present study provides in vivo evidence that Mcl-1 is a crucial antiapoptotic factor for the liver, contributing to hepatocellular homeostasis and protecting hepatocytes from apoptosis induction.
Authors: Konrad L Streetz; Frank Tacke; Ludger Leifeld; Torsten Wüstefeld; Andrea Graw; Christian Klein; Kenjii Kamino; Ulrich Spengler; Hans Kreipe; Stefan Kubicka; Werner Müller; Michael P Manns; Christian Trautwein Journal: Hepatology Date: 2003-07 Impact factor: 17.425
Authors: Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer Journal: Nature Date: 2003-12-11 Impact factor: 49.962
Authors: Henning Schulze-Bergkamen; Andreas Untergasser; Andreas Dax; Heiko Vogel; Peter Büchler; Ernst Klar; Thomas Lehnert; Helmut Friess; Markus W Büchler; Michael Kirschfink; Wolfgang Stremmel; Peter H Krammer; Martina Müller; Ulrike Protzer Journal: J Hepatol Date: 2003-06 Impact factor: 25.083
Authors: Michal Safran; William Y Kim; Andrew L Kung; James W Horner; Ron A DePinho; William G Kaelin Journal: Mol Imaging Date: 2003-10 Impact factor: 4.488
Authors: Jörn M Schattenberg; Marcus A Wörns; Tim Zimmermann; You-Wen He; Peter R Galle; Marcus Schuchmann Journal: Free Radic Biol Med Date: 2012-03-08 Impact factor: 7.376
Authors: Toni Urbanik; Bruno Christian Koehler; Laura Wolpert; Christin Elßner; Anna-Lena Scherr; Thomas Longerich; Nicole Kautz; Stefan Welte; Nadine Hövelmeyer; Dirk Jäger; Ari Waisman; Henning Schulze-Bergkamen Journal: World J Gastroenterol Date: 2014-12-07 Impact factor: 5.742